(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 27^th May, 2003)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

                                                                New Delhi, the 27^th May, 2003

ORDER

S.O.615(E)  – In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 950(E), dated 9th September, 2002, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority hereby fixes the prices as specified in column (5) of the table below as the ceiling price exclusive of excise duty, and local tax, if any, for scheduled formulation specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in column (3) and (4) thereof :

TABLE

NOTE :

(a)        The prices fixed are the maximum ceiling prices (exclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        Pro-rata pricing for packs of same composition but of different sizes, will be applicable vide S.O. No. 83(E) dated 27.1.1998.

(c)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

PN/69/2003/F

F.No. 8(47)/2003/D.P./NPPA-Div.II

(L. M. KAUSHAL)
Deputy Director
National Pharmaceutical Pricing Authority